Multiscale Anisotropic Scaffold Integrating 3D Printing and Electrospinning Techniques as a Heart‐on‐a‐Chip Platform for Evaluating Drug‐Induced Cardiotoxicity (Adv. Healthcare Mater. 24/2023)
Sitian LiuZihan WangXinyi ChenMingying HanJie XuTing LiLiu YuMaoyu QinMeng LongMingchuan LiHongwu ZhangYanbing LiLing WangWenhua HuangYaobin Wu
6
Citation
0
Reference
10
Related Paper
Citation Trend
Keywords:
Biofabrication
Cardiotoxicity
Electrospinning
Biofabrication In article number 2101309, Norbert Radacsi and co-workers show that the combination of electrospinning with 3D printing can create scaffolds suitable for cell growth. The electrospun nanofibers help to attract cells due to their extracellular matrix-like structure, while the 3D-printed parts can serve as macroscopic structure material.
Biofabrication
Electrospinning
Cite
Citations (3)
Abstract The process of electrohydrodynamic living cell microencapsulation inside a scaffold during the electrospinning (ES) process is called cell electrospinning (CE). Several studies demonstrate the feasibility of using cell electrospinning for biomedical applications, allowing for the direct biofabrication of living cells to be encapsulated in fibers for the formation of active biological scaffolds. In this review, a comprehensive overview of the materials and methodologies used in cell electrospinning, as well as their biomedical application in tissue engineering, is provided. Cell ES represents an innovative technique for automated application in regenerative medicine.
Biofabrication
Electrospinning
Regenerative Medicine
Cite
Citations (4)
Biofabrication is a fast-evolving and multi-disciplinary field, harnessing the benefits and capabilities of additive manufacturing and complementary bioassembly techniques at the intersection of biology and engineering. Biofabrication is promising for printing of transplantable tissues, though near-term applications in practice include biomimetically engineered models for drug discovery, cosmetics testing, tissue regeneration and medical devices. Recapitulating the structure and complexity of native tissues, however, remains a significant challenge. To address this, recent biofabrication work has demonstrated improvements in the scale, rate and intricacy at which tissues can be fabricated, with examples including work in volumetric bioprinting, scaffold-free bioassembly, and hybrid biofabrication strategies. These and other emerging techniques have the potential for the strategic arrangement of multiple materials, cells and extracellular matrix components at length scales down to the level of single cells. This review evaluates emerging biofabrication techniques and highlights their recent application and future potential in producing complex heterogeneous tissues.
Biofabrication
Cite
Citations (46)
The biofabrication of multi-cellular tissues or organoids (MTOs) has been challenging in regenerative medicine for decades. Currently, two primary technological approaches are being explored: scaffold-based strategies utilizing three-dimensional (3D) bioprinting techniques and scaffold-free strategies employing bioassembly techniques. 3D bioprinting techniques include jetting-based, extrusion-based, and vat photopolymerization-based methods, and bioassembly techniques include Kenzan, fluid-based manipulation and microfluid, bioprinting-assisted tissue emergence, and aspiration-assisted technology methods. Scaffold-based strategies primarily concentrate on the construction of scaffold structures to provide an extracellular environment, while scaffold-free strategies primarily emphasize the assembly methods of building blocks. Different biofabrication technologies have their advantages and limitations. This review provides an overview of the mechanisms, advantages, and limitations of scaffold-based and scaffold-free strategies in tissue engineering. It also compares the strengths and weaknesses of these two strategies, along with their respective suitability under different conditions. Moreover, the significant challenges in the future development of convergence strategies, specifically the integration of scaffold-based and scaffold-free approaches, are examined in an objective manner. This review concludes that integrating scaffold-based and scaffold-free strategies could overcome the problems in the biofabrication of MTOs. A novel fabrication method, the BioMicroMesh method, is proposed based on the convergence strategy. Concurrently, the development of a desktop-scale integrated intelligent biofabrication device, the BioMicroMesh system, is underway. This system is tailored to the BioMicroMesh method and incorporates cell aggregate spheroids preparation, 3D bioprinting, bioassembly, and multi-organoid co-culture functions, providing an objective perspective on its capabilities.
Biofabrication
3D bioprinting
Cite
Citations (3)
Abstract Biofabrication is roughly defined as techniques producing complex 2D and 3D tissues and organs from raw materials such as living cells, matrices, biomaterials, and molecules. It is useful for tissue engineering, regenerative medicine, drug screening, and organs‐on‐a‐chip. Biofabrication could be carried out by microfluidic techniques, optical methods, microfabrication, 3D bioprinting, etc. Meanwhile, electrochemical devices and/or systems have also been reported. In this progress report, the recent advances in applying these devices/systems for biofabrication are summarized. After introducing the concept of biofabrication, biofabrication strategies using electrochemical approaches are summarized. Then, various electrochemical systems such as probes and chip devices are described. Next, the biofabrication of hydrogels for 3D cell culture, electrochemical modification on cell culture surfaces, electrodeposition of conductive materials in hydrogels for cell culture, and biofabrication of cell aggregates using dielectrophoresis is discussed. In addition, electrochemical stimulation methods such as electrotaxis are mentioned as promising techniques for biofabrication. Finally, future research directions in this field and the application prospects are highlighted.
Biofabrication
Cite
Citations (20)
Biofabrication
Cite
Citations (85)
Abstract The mission of regenerative medicine is the development of methods to regrow, repair, or replace damaged or diseased cells, organs, or tissues. 3D bioprinting techniques are one of the most promising approaches for engineering the design of artificial tissues. Current 3D bioprinting technologies possess, however, several intrinsic limitations. 4D biofabrication, a recently developed technology with the embedded ability of shape transformation upon response to intrinsic and/or external stimuli, may solve challenges of 3D bioprinting as well as more accurately mimic the dynamics of the native tissues. This article covers recent advances in 4D biofabrication. It gives a detailed picture of used materials and technologies, provides critical comparisons of methods, discusses possibilities and limitations of different 4D biofabrication technologies, and gives examples of applications.
Biofabrication
Regenerative Medicine
3D bioprinting
Cite
Citations (93)
Scaffolding is the conceptual framework of conventional tissue engineering. Over the past decade, scaffold-free approaches as a potential alternative to classic scaffold-based methods have emerged, and scaffold-free magnetic levitational tissue engineering (magnetic force-based tissue engineering [Mag-TE]) is a type of this novel tissue engineering strategy. However, Mag-TE is often based on the use of potentially toxic magnetic nanoparticles. Scaffold-free and label-free magnetic levitational bioassembly do not employ magnetic nanoparticles and thus, the potential toxicity of magnetic nanoparticles can be avoided. In this short review, we describe the conceptual foundation of scaffold-free, label-free, and nozzle-free formative biofabrication using magnetic fields as "scaffields." The design and implementation of "Organ.Aut," the first commercial magnetic levitational bioassembler, and the potential applications of magnetic bioassembler are discussed as well.
Biofabrication
Cite
Citations (12)
Biofabrication can be defined as the production of complex living and non-living biological products from raw materials such as living cells, molecules, extracellular matrices, and biomaterials. Cell and developmental biology, biomaterials science, and mechanical engineering are the main disciplines contributing to the emergence of biofabrication technology. The industrial potential of biofabrication technology is far beyond the traditional medically oriented tissue engineering and organ printing and, in the short term, it is essential for developing potentially highly predictive human cell- and tissue-based technologies for drug discovery, drug toxicity, environmental toxicology assays, and complex in vitro models of human development and diseases. In the long term, biofabrication can also contribute to the development of novel biotechnologies for sustainable energy production in the future biofuel industry and dramatically transform traditional animal-based agriculture by inventing 'animal-free' food, leather, and fur products. Thus, the broad spectrum of potential applications and rapidly growing arsenal of biofabrication methods strongly suggests that biofabrication can become a dominant technological platform and new paradigm for 21st century manufacturing. The main objectives of this review are defining biofabrication, outlining the most essential disciplines critical for emergence of this field, analysis of the evolving arsenal of biofabrication technologies and their potential practical applications, as well as a discussion of the common challenges being faced by biofabrication technologies, and the necessary conditions for the development of a global biofabrication research community and commercially successful biofabrication industry.
Biofabrication
Cite
Citations (342)
With advances in tissue engineering, the possibility of regenerating injured tissue or failing organs has become a realistic prospect for the first time in medical history. Tissue engineering – the combination of bioactive materials with cells to generate engineered constructs that functionally replace lost and/or damaged tissue – is a major strategy to achieve this goal. One facet of tissue engineering is biofabrication, where three‐dimensional tissue‐like structures composed of biomaterials and cells in a single manufacturing procedure are generated. Cell‐laden hydrogels are commonly used in biofabrication and are termed “bioinks”. Hydrogels are particularly attractive for biofabrication as they recapitulate several features of the natural extracellular matrix and allow cell encapsulation in a highly hydrated mechanically supportive three‐dimensional environment. Additionally, they allow for efficient and homogeneous cell seeding, can provide biologically‐relevant chemical and physical signals, and can be formed in various shapes and biomechanical characteristics. However, despite the progress made in modifying hydrogels for enhanced bioactivation, cell survival and tissue formation, little attention has so far been paid to optimize hydrogels for the physico‐chemical demands of the biofabrication process. The resulting lack of hydrogel bioinks have been identified as one major hurdle for a more rapid progress of the field. In this review we summarize and focus on the deposition process, the parameters and demands of hydrogels in biofabrication, with special attention to robotic dispensing as an approach that generates constructs of clinically relevant dimensions. We aim to highlight this current lack of effectual hydrogels within biofabrication and initiate new ideas and developments in the design and tailoring of hydrogels. The successful development of a “printable” hydrogel that supports cell adhesion, migration, and differentiation will significantly advance this exciting and promising approach for tissue engineering.
Biofabrication
Cell encapsulation
Cite
Citations (1,704)